应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
KYTX Kyverna Therapeutics
未开盘 11-15 16:00:00 EST
4.35
-0.45
-9.37%
盘后
4.35
+0.00
0.00%
18:00 EST
最高
4.85
最低
4.30
成交量
28.02万
今开
4.85
昨收
4.80
日振幅
11.46%
总市值
1.88亿
流通市值
9,738万
总股本
4,317万
成交额
124.75万
换手率
1.25%
流通股本
2,239万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Kyverna Therapeutics, Inc.盘中异动 下午盘大幅下挫5.53%
市场透视 · 11-15
Kyverna Therapeutics, Inc.盘中异动 下午盘大幅下挫5.53%
Kyverna Therapeutics, Inc.盘中异动 下午盘大幅拉升5.10%
市场透视 · 11-12
Kyverna Therapeutics, Inc.盘中异动 下午盘大幅拉升5.10%
Kyverna Therapeutics, Inc.盘中异动 早盘股价大涨6.04%报5.44美元
市场透视 · 11-07
Kyverna Therapeutics, Inc.盘中异动 早盘股价大涨6.04%报5.44美元
Kyverna Therapeutics, Inc.盘中异动 早盘股价大涨7.07%报5.45美元
市场透视 · 11-06
Kyverna Therapeutics, Inc.盘中异动 早盘股价大涨7.07%报5.45美元
Kyverna Therapeutics, Inc.盘中异动 快速拉升5.11%报5.14美元
市场透视 · 11-05
Kyverna Therapeutics, Inc.盘中异动 快速拉升5.11%报5.14美元
Kyverna Therapeutics, Inc.盘中异动 快速下跌5.08%报5.05美元
市场透视 · 10-31
Kyverna Therapeutics, Inc.盘中异动 快速下跌5.08%报5.05美元
Kyverna Therapeutics, Inc.盘中异动 早盘大幅上涨5.23%报5.63美元
市场透视 · 10-30
Kyverna Therapeutics, Inc.盘中异动 早盘大幅上涨5.23%报5.63美元
Kyverna Therapeutics, Inc.盘中异动 股价大涨5.43%
市场透视 · 10-26
Kyverna Therapeutics, Inc.盘中异动 股价大涨5.43%
Kyverna Therapeutics, Inc.盘中异动 早盘急速下挫5.12%报5.35美元
市场透视 · 10-21
Kyverna Therapeutics, Inc.盘中异动 早盘急速下挫5.12%报5.35美元
Kyverna Therapeutics, Inc.盘中异动 股价大涨5.05%
市场透视 · 10-11
Kyverna Therapeutics, Inc.盘中异动 股价大涨5.05%
Kyverna Therapeutics, Inc.盘中异动 急速上涨5.29%报4.98美元
市场透视 · 10-03
Kyverna Therapeutics, Inc.盘中异动 急速上涨5.29%报4.98美元
Kyverna Therapeutics, Inc.盘中异动 股价大跌5.35%
市场透视 · 10-01
Kyverna Therapeutics, Inc.盘中异动 股价大跌5.35%
Kyverna Therapeutics, Inc.盘中异动 急速下挫5.05%
市场透视 · 09-25
Kyverna Therapeutics, Inc.盘中异动 急速下挫5.05%
Kyverna Therapeutics, Inc.盘中异动 快速下跌5.17%报6.06美元
市场透视 · 09-23
Kyverna Therapeutics, Inc.盘中异动 快速下跌5.17%报6.06美元
Kyverna Therapeutics, Inc.盘中异动 下午盘急速下跌5.06%
市场透视 · 09-21
Kyverna Therapeutics, Inc.盘中异动 下午盘急速下跌5.06%
小摩:维持Kyverna Therapeutics(KYTX.US)评级,由增持调整至增持评级, 目标价由39.00美元调整至33.
智通财经 · 08-01
小摩:维持Kyverna Therapeutics(KYTX.US)评级,由增持调整至增持评级, 目标价由39.00美元调整至33.
Kyverna Therapeutics公司:JP Morgan将目标价从39美元下调至33美元。
智通财经 · 07-31
Kyverna Therapeutics公司:JP Morgan将目标价从39美元下调至33美元。
BUZZ-Kyverna公司的硬皮症药物获得美国食品药品管理局的RMAT认定后股价上涨
Reuters · 07-16
BUZZ-Kyverna公司的硬皮症药物获得美国食品药品管理局的RMAT认定后股价上涨
Kyverna Therapeutics(KYTX.US)获HC Wainwright & Co.首次覆盖,给予中性评级, 目标价8.
智通财经 · 07-03
Kyverna Therapeutics(KYTX.US)获HC Wainwright & Co.首次覆盖,给予中性评级, 目标价8.
Kyverna Therapeutics, Inc:H.C. Wainwright发起覆盖评级为中性目标价为8美元。
智通财经 · 07-03
Kyverna Therapeutics, Inc:H.C. Wainwright发起覆盖评级为中性目标价为8美元。
暂无数据
公司概况
公司名称:
Kyverna Therapeutics
所属市场:
NASDAQ
上市日期:
--
主营业务:
Kyverna Therapeutics, Inc.于2018年6月以BAIT Therapeutics, Inc.的名义在特拉华州注册成立,并于2019年10月更名为Kyverna Therapeutics, Inc.。该公司是一家以患者为中心的临床阶段生物制药公司,专注于为患有自身免疫性疾病的患者开发细胞疗法。他们的目标是通过以患者为中心的方法、广泛的平台、对治疗免疫疾病的见解以及从细胞疗法在其他医学领域的成功应用中获得的经验,为患有自身免疫性疾病的患者带来改善疾病的治疗益处。
发行价格:
--
{"stockData":{"symbol":"KYTX","market":"US","secType":"STK","nameCN":"Kyverna Therapeutics","latestPrice":4.35,"timestamp":1731704400000,"preClose":4.8,"halted":0,"volume":280159,"hourTrading":{"tag":"盘后","latestPrice":4.35,"preClose":4.35,"latestTime":"18:00 EST","volume":1210,"amount":5274.51,"timestamp":1731711650681},"delay":0,"floatShares":22385672,"shares":43171612,"eps":-3.991049,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.45,"latestTime":"11-15 16:00:00 EST","open":4.85,"high":4.85,"low":4.3,"amount":1247468.0135895999,"amplitude":0.114583,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-3.991049,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1731920400000},"adr":0,"listingDate":1707368400000,"adjPreClose":4.8,"preHourTrading":{"tag":"盘前","latestPrice":4.8,"preClose":4.8,"latestTime":"08:41 EST","volume":1,"amount":4.8,"timestamp":1731678074869},"postHourTrading":{"tag":"盘后","latestPrice":4.35,"preClose":4.35,"latestTime":"18:00 EST","volume":1210,"amount":5274.51,"timestamp":1731711650681},"volumeRatio":1.2802598190046721,"impliedVol":2.3012,"impliedVolPercentile":0.9023},"requestUrl":"/m/hq/s/KYTX/tweets","defaultTab":"tweets","newsList":[{"id":"2483334125","title":"Kyverna Therapeutics, Inc.盘中异动 下午盘大幅下挫5.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483334125","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483334125?lang=zh_cn&edition=full","pubTime":"2024-11-15 04:12","pubTimestamp":1731615135,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日04时12分,Kyverna Therapeutics, Inc.股票出现波动,股价大幅跳水5.53%。Kyverna Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为1.46%。其相关个股中,60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Molecular Templates, Inc.涨幅较大,Molecular Templates, Inc.、Elevai Labs, Inc.、Pulmatrix, Inc.较为活跃,换手率分别为4776.89%、3426.85%、396.84%,振幅较大的相关个股有Molecular Templates, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ,振幅分别为249.67%、211.36%、188.46%。Kyverna Therapeutics, Inc.公司简介:Kyverna Therapeutics Inc 是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115041216971a6a18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115041216971a6a18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KYTX","LENZ"],"gpt_icon":0},{"id":"2482750491","title":"Kyverna Therapeutics, Inc.盘中异动 下午盘大幅拉升5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482750491","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482750491?lang=zh_cn&edition=full","pubTime":"2024-11-12 04:11","pubTimestamp":1731355872,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日04时11分,Kyverna Therapeutics, Inc.股票出现异动,股价大幅拉升5.10%。截至发稿,该股报5.56美元/股,成交量9.1946万股,换手率0.21%,振幅4.73%。Kyverna Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.94%。其相关个股中,Cero Therapeutics Holdings, Inc.、Geovax Labs, Inc.、Aligos Therapeutics, Inc.涨幅较大,Cero Therapeutics Holdings, Inc.、Revelation Biosciences, Inc.、Geovax Labs, Inc.较为活跃,换手率分别为885.57%、515.26%、317.50%,振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Aligos Therapeutics, Inc.、Geovax Labs Inc C/Wts 29/09/2025,振幅分别为132.14%、72.42%、65.93%。Kyverna Therapeutics, Inc.公司简介:Kyverna Therapeutics Inc 是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112041112971a5cc6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112041112971a5cc6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","KYTX"],"gpt_icon":0},{"id":"2481877221","title":"Kyverna Therapeutics, Inc.盘中异动 早盘股价大涨6.04%报5.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481877221","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481877221?lang=zh_cn&edition=full","pubTime":"2024-11-07 23:44","pubTimestamp":1730994295,"startTime":"0","endTime":"0","summary":"北京时间2024年11月07日23时44分,Kyverna Therapeutics, Inc.股票出现异动,股价大幅上涨6.04%。截至发稿,该股报5.44美元/股,成交量5.6502万股,换手率0.13%,振幅4.58%。Kyverna Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.26%。其相关个股中,Ensysce Biosciences, Inc.、Celularity Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 涨幅较大,Ensysce Biosciences, Inc.、Elevai Labs, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃,换手率分别为732.32%、155.03%、94.27%,振幅较大的相关个股有Celularity Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Ensysce Biosciences, Inc.,振幅分别为84.83%、68.89%、57.79%。Kyverna Therapeutics, Inc.公司简介:Kyverna Therapeutics Inc 是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107234455abaa998a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107234455abaa998a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KYTX","LENZ"],"gpt_icon":0},{"id":"2481855649","title":"Kyverna Therapeutics, Inc.盘中异动 早盘股价大涨7.07%报5.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481855649","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481855649?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:32","pubTimestamp":1730903567,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时32分,Kyverna Therapeutics, Inc.股票出现波动,股价急速上涨7.07%。截至发稿,该股报5.45美元/股,成交量5662股,换手率0.01%,振幅3.14%。Kyverna Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.49%。其相关个股中,Sonnet Biotherapeutics Holdings, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大,Sonnet Biotherapeutics Holdings, Inc.、Elevai Labs, Inc.、Zyversa Therapeutics, Inc.较为活跃,换手率分别为1070.77%、101.26%、52.67%,振幅较大的相关个股有Fate Therapeutics, Inc.、Nurix Therapeutics, Inc.、Inmed Pharmaceuticals Inc.,振幅分别为107.84%、106.06%、106.04%。Kyverna Therapeutics, Inc.公司简介:Kyverna Therapeutics Inc 是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622324898e40dd2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622324898e40dd2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KYTX","LENZ"],"gpt_icon":0},{"id":"2481534435","title":"Kyverna Therapeutics, Inc.盘中异动 快速拉升5.11%报5.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481534435","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481534435?lang=zh_cn&edition=full","pubTime":"2024-11-05 01:27","pubTimestamp":1730741278,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日01时27分,Kyverna Therapeutics, Inc.股票出现异动,股价快速拉升5.11%。截至发稿,该股报5.14美元/股,成交量7.953万股,换手率0.18%,振幅6.95%。Kyverna Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.08%。其相关个股中,Neurogene Inc.、Tenaya Therapeutics, Inc.、Disc Medicine, Inc.涨幅较大,Elevai Labs, Inc.、Nls Pharmaceutics Ltd.、Gri Bio, Inc.较为活跃,换手率分别为355.48%、275.03%、79.54%,振幅较大的相关个股有Sab Biotherapeutics Inc C/Wts 22/10/2026 、In8Bio, Inc.、Neurogene Inc.,振幅分别为52.25%、45.39%、39.98%。Kyverna Therapeutics, Inc.公司简介:Kyverna Therapeutics Inc 是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105012758971a4396&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105012758971a4396&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KYTX","LENZ","BK4139"],"gpt_icon":0},{"id":"2479349460","title":"Kyverna Therapeutics, Inc.盘中异动 快速下跌5.08%报5.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479349460","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479349460?lang=zh_cn&edition=full","pubTime":"2024-10-31 22:53","pubTimestamp":1730386395,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日22时53分,Kyverna Therapeutics, Inc.股票出现异动,股价快速下跌5.08%。Kyverna Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为3.42%。其相关个股中,Ocean Biomedical Inc C/Wts 14/02/2028 、Mimedx Group, Inc、180 Life Sciences Corp C/Wts 07/11/2025涨幅较大,Aditxt, Inc.、Evogene Ltd.、Palisade Bio, Inc.较为活跃,换手率分别为242.36%、231.08%、162.53%,振幅较大的相关个股有180 Life Sciences Corp C/Wts 07/11/2025、Cingulate Inc C/Wts 10/12/2026 、Vaccinex, Inc.,振幅分别为46.15%、39.30%、37.72%。Kyverna Therapeutics, Inc.公司简介:Kyverna Therapeutics Inc 是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031225315971a3964&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031225315971a3964&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KYTX","LENZ"],"gpt_icon":0},{"id":"2479119786","title":"Kyverna Therapeutics, Inc.盘中异动 早盘大幅上涨5.23%报5.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479119786","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479119786?lang=zh_cn&edition=full","pubTime":"2024-10-30 21:34","pubTimestamp":1730295284,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日21时34分,Kyverna Therapeutics, Inc.股票出现异动,股价快速上涨5.23%。截至发稿,该股报5.63美元/股,成交量2.4197万股,换手率0.06%,振幅5.42%。Kyverna Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.17%。其相关个股中,Tharimmune, Inc.、Calcimedica, Inc.、Ensysce Biosciences, Inc.涨幅较大,Tharimmune, Inc.、Ensysce Biosciences, Inc.、Tc Biopharm Plc较为活跃,换手率分别为2027.18%、104.67%、17.89%,振幅较大的相关个股有Tharimmune, Inc.、Ensysce Biosciences, Inc.、Quince Therapeutics, Inc.,振幅分别为53.69%、17.66%、16.26%。Kyverna Therapeutics, Inc.公司简介:Kyverna Therapeutics Inc 是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103021344598e3f675&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103021344598e3f675&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KYTX","LENZ","BK4139"],"gpt_icon":0},{"id":"2478795142","title":"Kyverna Therapeutics, Inc.盘中异动 股价大涨5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478795142","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478795142?lang=zh_cn&edition=full","pubTime":"2024-10-26 01:09","pubTimestamp":1729876187,"startTime":"0","endTime":"0","summary":"北京时间2024年10月26日01时09分,Kyverna Therapeutics, Inc.股票出现波动,股价大幅上涨5.43%。截至发稿,该股报5.24美元/股,成交量9.7822万股,换手率0.23%,振幅6.44%。Kyverna Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.72%。其相关个股中,Iterum Therapeutics Plc、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Immunitybio, Inc.涨幅较大,180 Life Sciences Corp.、Elevai Labs, Inc.、Iterum Therapeutics Plc较为活跃,换手率分别为838.54%、765.26%、310.95%,振幅较大的相关个股有Iterum Therapeutics Plc、Qualigen Therapeutics, Inc.、Elevai Labs, Inc.,振幅分别为102.56%、91.58%、89.80%。Kyverna Therapeutics, Inc.公司简介:Kyverna Therapeutics Inc 是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241026010947971a2609&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241026010947971a2609&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KYTX","BK4139","LENZ"],"gpt_icon":0},{"id":"2477623068","title":"Kyverna Therapeutics, Inc.盘中异动 早盘急速下挫5.12%报5.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477623068","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477623068?lang=zh_cn&edition=full","pubTime":"2024-10-21 22:58","pubTimestamp":1729522687,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日22时58分,Kyverna Therapeutics, Inc.股票出现波动,股价大幅下跌5.12%。截至发稿,该股报5.35美元/股,成交量4.718万股,换手率0.11%,振幅5.96%。Kyverna Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.47%。其相关个股中,Genprex, Inc.、Biovie Inc.、Apollomics Inc C/Wts 01/04/2028 涨幅较大,Genprex, Inc.、Biovie Inc.、Aptevo Therapeutics Inc.较为活跃,换手率分别为5204.57%、1192.03%、758.10%,振幅较大的相关个股有Genprex, Inc.、Biovie Inc.、Aptevo Therapeutics Inc.,振幅分别为323.73%、157.02%、118.79%。Kyverna Therapeutics, Inc.公司简介:Kyverna Therapeutics Inc 是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102122580898e3d906&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102122580898e3d906&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","KYTX"],"gpt_icon":0},{"id":"2474701803","title":"Kyverna Therapeutics, Inc.盘中异动 股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474701803","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474701803?lang=zh_cn&edition=full","pubTime":"2024-10-11 22:42","pubTimestamp":1728657760,"startTime":"0","endTime":"0","summary":"北京时间2024年10月11日22时42分,Kyverna Therapeutics, Inc.股票出现波动,股价大幅拉升5.05%。Kyverna Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.08%。其相关个股中,Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Conduit Pharmaceuticals Inc.、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大,Conduit Pharmaceuticals Inc.、Aditxt, Inc.、Gritstone Bio, Inc.较为活跃,换手率分别为232.24%、123.60%、21.40%,振幅较大的相关个股有Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Tc Biopharm Plc C/Wts 10/02/2028 、Nutriband Inc C/Wts ,振幅分别为170.59%、70.00%、47.62%。Kyverna Therapeutics, Inc.公司简介:Kyverna Therapeutics Inc 是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241011224240a1e00520&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241011224240a1e00520&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KYTX","LENZ","BK4139"],"gpt_icon":0},{"id":"2472861549","title":"Kyverna Therapeutics, Inc.盘中异动 急速上涨5.29%报4.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472861549","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472861549?lang=zh_cn&edition=full","pubTime":"2024-10-03 21:30","pubTimestamp":1727962243,"startTime":"0","endTime":"0","summary":"北京时间2024年10月03日21时30分,Kyverna Therapeutics, Inc.股票出现异动,股价快速上涨5.29%。截至发稿,该股报4.98美元/股,成交量1526股,换手率0.00%,振幅0.00%。Kyverna Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.00%。其相关个股中,Psyence Biomedical Ltd C/Wts 25/01/2029、Elevai Labs, Inc.、Theriva Biologics, Inc.涨幅较大,Theriva Biologics, Inc.、Aditxt, Inc.、Elevai Labs, Inc.较为活跃,换手率分别为1555.16%、633.54%、350.66%,振幅较大的相关个股有Elevai Labs, Inc.、Theriva Biologics, Inc.、Inmed Pharmaceuticals Inc.,振幅分别为19.25%、11.28%、10.29%。Kyverna Therapeutics, Inc.公司简介:Kyverna Therapeutics Inc 是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100321304398e3a656&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100321304398e3a656&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KYTX","LENZ","BK4139"],"gpt_icon":0},{"id":"2472833958","title":"Kyverna Therapeutics, Inc.盘中异动 股价大跌5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472833958","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472833958?lang=zh_cn&edition=full","pubTime":"2024-10-01 00:41","pubTimestamp":1727714487,"startTime":"0","endTime":"0","summary":"北京时间2024年10月01日00时41分,Kyverna Therapeutics, Inc.股票出现波动,股价快速下挫5.35%。Kyverna Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.19%。其相关个股中,Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Nkgen Biotech Inc C/Wts 31/05/2028、Capricor Therapeutics, Inc.涨幅较大,Aditxt, Inc.、Gri Bio, Inc.、Seelos Therapeutics, Inc.较为活跃,换手率分别为153.60%、55.15%、45.82%,振幅较大的相关个股有Tc Biopharm Plc C/Wts 10/02/2028 、Capricor Therapeutics, Inc.、Kezar Life Sciences, Inc.,振幅分别为85.25%、45.53%、39.49%。Kyverna Therapeutics, Inc.公司简介:Kyverna Therapeutics Inc 是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100100412798e39e3c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100100412798e39e3c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KYTX","LENZ"],"gpt_icon":0},{"id":"2470443074","title":"Kyverna Therapeutics, Inc.盘中异动 急速下挫5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470443074","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470443074?lang=zh_cn&edition=full","pubTime":"2024-09-25 02:59","pubTimestamp":1727204397,"startTime":"0","endTime":"0","summary":"北京时间2024年09月25日02时59分,Kyverna Therapeutics, Inc.股票出现波动,股价急速下挫5.05%。Kyverna Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为1.39%。其相关个股中,Seelos Therapeutics, Inc.、Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 、Wave Life Sciences Ltd.涨幅较大,Seelos Therapeutics, Inc.、Silexion Therapeutics Corp、Onconetix, Inc.较为活跃,换手率分别为4604.30%、200.75%、178.90%,振幅较大的相关个股有Seelos Therapeutics, Inc.、Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ,振幅分别为122.95%、65.30%、60.77%。Kyverna Therapeutics, Inc.公司简介:Kyverna Therapeutics Inc 是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092502595798e38b69&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092502595798e38b69&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KYTX","LENZ"],"gpt_icon":0},{"id":"2469112372","title":"Kyverna Therapeutics, Inc.盘中异动 快速下跌5.17%报6.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469112372","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469112372?lang=zh_cn&edition=full","pubTime":"2024-09-23 21:31","pubTimestamp":1727098310,"startTime":"0","endTime":"0","summary":"北京时间2024年09月23日21时31分,Kyverna Therapeutics, Inc.股票出现波动,股价快速下挫5.17%。截至发稿,该股报6.06美元/股,成交量9653股,换手率0.02%,振幅1.72%。Kyverna Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.26%。其相关个股中,Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Pharmacyte Biotech, Inc.、Cingulate Inc C/Wts 10/12/2026 涨幅较大,Black Diamond Therapeutics, Inc.、Galmed Pharmaceuticals Ltd.、Scisparc Ltd.较为活跃,换手率分别为25.72%、24.45%、22.42%,振幅较大的相关个股有Pharmacyte Biotech, Inc.、天演药业、Skye Bioscience, Inc.,振幅分别为18.52%、13.14%、10.99%。Kyverna Therapeutics, Inc.公司简介:Kyverna Therapeutics Inc 是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240923213150a1dbec2e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240923213150a1dbec2e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KYTX","LENZ"],"gpt_icon":0},{"id":"2469467769","title":"Kyverna Therapeutics, Inc.盘中异动 下午盘急速下跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2469467769","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469467769?lang=zh_cn&edition=full","pubTime":"2024-09-21 02:16","pubTimestamp":1726856171,"startTime":"0","endTime":"0","summary":"北京时间2024年09月21日02时16分,Kyverna Therapeutics, Inc.股票出现异动,股价大幅跳水5.06%。Kyverna Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为2.16%。其相关个股中,Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Novabay Pharmaceuticals, Inc.涨幅较大,Novabay Pharmaceuticals, Inc.、Galmed Pharmaceuticals Ltd.、Cero Therapeutics Holdings, Inc.较为活跃,换手率分别为2273.72%、2185.74%、250.02%,振幅较大的相关个股有Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 、Cero Therapeutics Holdings, Inc.、Fresh2 Group Limited,振幅分别为165.20%、148.05%、88.14%。Kyverna Therapeutics, Inc.公司简介:Kyverna Therapeutics Inc 是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240921021612a1db7db2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240921021612a1db7db2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","KYTX"],"gpt_icon":0},{"id":"2456665031","title":"小摩:维持Kyverna Therapeutics(KYTX.US)评级,由增持调整至增持评级, 目标价由39.00美元调整至33.","url":"https://stock-news.laohu8.com/highlight/detail?id=2456665031","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456665031?lang=zh_cn&edition=full","pubTime":"2024-08-01 02:37","pubTimestamp":1722451058,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0234572021.USD","LU","LU1162221912.USD","LU1670627923.USD","LU0211326839.USD","LU1244550577.SGD","KYTX","LENZ","LU0211328371.USD","LU1244550221.USD","IE00BJTD4N35.SGD","LU1670628061.USD","IE00BKVL7J92.USD","BK4581","BK4504","BK4516","IE00BZ1G4Q59.USD","LU1267930490.SGD","BK4533","LU0417517546.SGD","LU0149725797.USD","LU1363072403.SGD","BK4585","IE00BLSP4239.USD","IE00B1BXHZ80.USD","LU0106831901.USD","LU0238689110.USD","LU1668664300.SGD","LU1894683264.USD","IE0034235188.USD","BK4566","IE00B775SV38.USD","IE00BHPRN162.USD","IE00BLSP4452.SGD","IE00BWXC8680.SGD","LU0320765646.SGD","LU0310799852.SGD","IE00BBT3K403.USD","BK4207","LU0170899867.USD","LU0882574139.USD","LU0971096721.USD","LU1261432733.SGD","IE00BFXG1179.USD","LU0320765489.SGD","LU0496365809.HKD","LU0211326755.USD","IE00BJTD4V19.USD","LU0208291251.USD","LU1496350171.SGD"],"gpt_icon":0},{"id":"2455979068","title":"Kyverna Therapeutics公司:JP Morgan将目标价从39美元下调至33美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2455979068","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455979068?lang=zh_cn&edition=full","pubTime":"2024-07-31 15:08","pubTimestamp":1722409709,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1989772923.USD","BK4588","LU0098860793.USD","LU1162221912.USD","LU1074936037.SGD","LU0106831901.USD","BK4581","LU1989772840.SGD","LU1363072403.SGD","IE00BKVL7J92.USD","KYTX","LU1668664300.SGD","BK4504","BK4534","LU0320765646.SGD","BK4127","LENZ","LU0267386448.USD","BK4139","BK4585","IE00BZ1G4Q59.USD","LU0314104364.USD","LU0971096721.USD"],"gpt_icon":0},{"id":"2451378609","title":"BUZZ-Kyverna公司的硬皮症药物获得美国食品药品管理局的RMAT认定后股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2451378609","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451378609?lang=zh_cn&edition=full","pubTime":"2024-07-16 06:00","pubTimestamp":1721080829,"startTime":"0","endTime":"0","summary":" 7月15日 - ** 生物制药公司Kyverna Therapeutics 的股价在盘后交易中上涨近9%,达到10.8美元** 公司的嵌合抗原受体T细胞候选产品KYV-101获得美国FDA再生医学高级疗法 认证** KYV-101将用于治疗难治性僵人综合症患者,该综合症是一种罕见的进行性神经系统自身免疫性疾病,影响患者的行走或活动能力。** KYTX表示,RMAT指定将使其能够 \"从FDA高级官员那里获得关于高效药物开发和替代终点使用的专家指导\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KYTX","BUZZ"],"gpt_icon":0},{"id":"2448170932","title":"Kyverna Therapeutics(KYTX.US)获HC Wainwright & Co.首次覆盖,给予中性评级, 目标价8.","url":"https://stock-news.laohu8.com/highlight/detail?id=2448170932","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448170932?lang=zh_cn&edition=full","pubTime":"2024-07-03 18:19","pubTimestamp":1720001998,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LENZ","BK4139","KYTX"],"gpt_icon":0},{"id":"2448457177","title":"Kyverna Therapeutics, Inc:H.C. Wainwright发起覆盖评级为中性目标价为8美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2448457177","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448457177?lang=zh_cn&edition=full","pubTime":"2024-07-03 18:06","pubTimestamp":1720001198,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LENZ","BK4139","KYTX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://kyvernatx.com","stockEarnings":[{"period":"1week","weight":-0.1777},{"period":"1month","weight":-0.2134},{"period":"3month","weight":-0.3546},{"period":"6month","weight":-0.7179},{"period":"1year","weight":-0.8023},{"period":"ytd","weight":-0.8023}],"compareEarnings":[{"period":"1week","weight":-0.0208},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0567},{"period":"6month","weight":0.1063},{"period":"1year","weight":0.301},{"period":"ytd","weight":0.2324}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Kyverna Therapeutics, Inc.于2018年6月以BAIT Therapeutics, Inc.的名义在特拉华州注册成立,并于2019年10月更名为Kyverna Therapeutics, Inc.。该公司是一家以患者为中心的临床阶段生物制药公司,专注于为患有自身免疫性疾病的患者开发细胞疗法。他们的目标是通过以患者为中心的方法、广泛的平台、对治疗免疫疾病的见解以及从细胞疗法在其他医学领域的成功应用中获得的经验,为患有自身免疫性疾病的患者带来改善疾病的治疗益处。","exchange":"NASDAQ","name":"Kyverna Therapeutics","nameEN":"Kyverna Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Kyverna Therapeutics(KYTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Kyverna Therapeutics(KYTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Kyverna Therapeutics,KYTX,Kyverna Therapeutics股票,Kyverna Therapeutics股票老虎,Kyverna Therapeutics股票老虎国际,Kyverna Therapeutics行情,Kyverna Therapeutics股票行情,Kyverna Therapeutics股价,Kyverna Therapeutics股市,Kyverna Therapeutics股票价格,Kyverna Therapeutics股票交易,Kyverna Therapeutics股票购买,Kyverna Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Kyverna Therapeutics(KYTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Kyverna Therapeutics(KYTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}